Press Release – ESC 2019 : Aspirin : Where we are now and were we are going

Press Release Aspirin: Where we are now and where we are going Join us in Paris during ESC 2019 for an intimate meeting with members of the International Aspirin Foundation’s Scientific Advisory Board, on Monday 2nd September at the Balzac – The Hub from 4.00-4.30pm. Professors Peter Rothwell (University of Oxford); Lina Badimon (Cardiovascular Research […]

Podcast – Richard Peto on BBC Radio 4

PODCAST – RICHARD PETO ON BBC RADIO 4 THE LIFE SCIENTIFIC (April 2019) Big data pioneer Richard Peto combined evidence of huge clinical trials from cancer to heart disease and showed that taking seriously the causes of the big killers saves lives. Hear the interview on the video below.

Press Release – Scientific Conference 2019

Press Release Global meeting to facilitate multidisciplinary debate on the risks and benefits of antithrombotic therapy. With a wealth of new data supporting the role of antithrombotic drugs in cardiovascular disease (CVD) prevention reaching publication over the last few years, the opportunity for world experts from a mix of disciplines to meet and put this […]

Emerging Investigator Award Winner 2018

Dr Andrew Chan presents Emerging Aspirin Investigator Science Award The International Aspirin Foundation’s Science Award for the Emerging Aspirin Investigator is open to junior scientists in the early stages of their research career, who are contributing to the knowledge of aspirin through original independent scientific research in the field of experimental and/or clinical medicine. The […]

Senior Science Award Winner – Paola Patrignani

Professor Peter Rothwell presents Senior Science Award Paola Patrignani, a highly regarded Professor from Italy, is the winner of the 2018 International Aspirin Foundation Senior Science Award.  Paola’s dedication to aspirin research has greatly increased our understanding of how aspirin works within the human body and this work has had a major impact on both […]

New Trial Data

​Two of the three recently completed primary prevention trials of low-dose aspirin were presented at the European Society of Cardiology Congress in Munich and simultaneously published online on August 26th.1,2 A Study of Cardiovascular Events in Diabetes2 (ASCEND, funded by the British Heart Foundation) was performed to assess the efficacy and safety of enteric-coated aspirin […]

S2TOP-BLEED

Follow this link to download a pdf copy of the press release The S2TOP-BLEED score may be helpful to identify patients on antiplatelet therapy following a transient ischemic attack or ischaemic stroke that are at high risk of bleeding. The S2TOP-BLEED score may help identify a sub group of high risk patients where gastro protective […]

Aspirin’s synergistic role in cancer immunotherapy

Follow this link to download a pdf copy of the press release Aspirin use appears to improve survival post diagnosis in colorectal cancers  with certain genetic mutations  Immune check point inhibitors against the PDCD1 (programmed cell death 1, PD-1) to CD274 (PDCD1 ligand, PD-1) axis have shown exciting clinical benefits in the treatment of refractory […]

Press Release – Conference Lectures

Press Release – December 2017Aspirin celebrates 120 years of innovation – gain access to the lectures World experts from the medical and scientific community met in Berlin to celebrate and explore the current understanding of aspirin’s multifaceted role in modern Medicine.  It is remarkable, 120 years on from when Aspirin was first synthesised by Dr […]